Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy

VOGELSTEIN B, 2004, Nat. Med., 10, 789, 10.1038/nm1087

HANAHAN D, 2000, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

10.1038/nrd839

10.1056/NEJM200103153441101

HURWITZ H, 2004, N Engl. J. Med., 350, 2335, 10.1056/NEJMoa032691

10.1056/NEJM200104053441404

DRUKER BJ, 2001, N. Engl. J. Med., 344, 1038, 10.1056/NEJM200104053441402

DRUKER BJ, 2001, N Engl. J. Med., 344, 1031, 10.1056/NEJM200104053441401

BHOWMICK NA, 2004, Nature, 432, 332, 10.1038/nature03096

BISSELL MJ, 2001, Nat. Rev Cancer, 1, 46, 10.1038/35094059

10.1038/nrc1477

ERICKSON AC, 2003, Expert Opin. Ther. Targets, 7, 71, 10.1517/14728222.7.1.71

FOLKMAN J, 2004, Nature, 427, 787, 10.1038/427787a

10.1056/NEJM197111182852108

ROSENBERG SA, 2004, Nat. Med., 10, 909, 10.1038/nm1100

RONNOV-JESSEN L, 1996, Physiol Rev, 76, 69, 10.1152/physrev.1996.76.1.69

RONNOV-JESSEN L, 1995, Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. ./. Clin. Invest., 95, 859

DVORAK HF, 1986, Similarities between tumor stroma generation and wound healing. N Engl. J. Med., 315, 1650

DOLBERG DS, 1985, Science, 230, 676, 10.1126/science.2996144

DUNHAM LJ, 1972, Cancer Res., 32, 1359

KORNFELD D, 1997, Gut, 41, 522, 10.1136/gut.41.4.522

PEEK RM, 2002, Nat. Rev Cancer, 2, 28, 10.1038/nrc703

BRIGATI C, 2002, Exp. Metastasis, 19, 247, 10.1023/A:1015587423262

BARCELLOS-HOFF MH, 2005, Semi]. Cancer Biol., 15, 138, 10.1016/j.semcancer.2004.08.010

BARCELLOS-HOFF MH, 2000, Cancer Res., 60, 1254

OHUCHIDA K, 2004, Cancer Res., 64, 3215, 10.1158/0008-5472.CAN-03-2464

MOINFAR F, 2000, Cancer Res., 60, 2562

KUROSE K, 2002, Nat. Genet., 32, 355, 10.1038/ng1013

HU M, 2005, Nat. Genet., 37, 899, 10.1038/ng1596

JACOBY RE SCHLACK S, COLE CE et al, 1997, Gastroenterology, 112, 1398, 10.1016/S0016-5085(97)70156-2

KIARIS H, 2005, Cancer Res., 65, 1627, 10.1158/0008-5472.CAN-04-3791

RONNOV-JESSEN L, 1993, Implications for myofibroblast generation in breast neoplasia. Lab. Invest., 68, 696

MOSES HL, 1990, Cell, 63, 245, 10.1016/0092-8674(90)90155-8

BISSELL DM, 2001, Exp. Mal Med., 33, 179, 10.1038/emm.2001.31

10.1016/j.cytogfr.2004.03.006

HAUPTMANN S, 2003, Eur. J. Cell Biol., 82, 1, 10.1078/0171-9335-00283

DECOSSE JJ, 1975, J. Nati Cancer Inst., 54, 913

DECOSSE JJ, 1973, Science, 181, 1057, 10.1126/science.181.4104.1057

MAEHARA N, 2001, Br. J. Cancer, 84, 864, 10.1054/bjoc.2000.1682

OLUMI AF, 1999, Cancer Res., 59, 5002

HAYWARD SW, 2001, Cancer Res., 61, 8135

SATO N, 2004, Cancer Res., 64, 6950, 10.1158/0008-5472.CAN-04-0677

KUNZ-SCHUGHART LA, 2001, Exp. Cell Res., 266, 74, 10.1006/excr.2001.5210

CAMPS JL, 1990, Proc. Nati Acad. Sri. USA, 87, 75, 10.1073/pnas.87.1.75

NOEL A, 1993, Matrix, 13, 267, 10.1016/S0934-8832(11)80021-1

GLEAVE M, 1991, Cancer Res., 51, 3753

TUXHORN JA, 2002, Cancer Res., 62, 3298

PARROTT JA, 2001, Mol. Endocrinol., 175, 29, 10.1016/S0303-7207(01)00436-1

BARCLAY WW, 2005, Endocrinology, 146, 13, 10.1210/en.2004-1123

10.1016/j.cell.2005.02.034

STERNLICHT MD, 1999, Cell, 98, 137, 10.1016/S0092-8674(00)81009-0

FORSBERG K, 1993, Proc. Nati Acad. Sri USA, 90, 393, 10.1073/pnas.90.2.393

GRUM-SCHWENSEN B, 2005, Cancer Res., 65, 3772, 10.1158/0008-5472.CAN-04-4510

KUHN R, 2002, Methods Mol. Biol., 180, 175

BERKING C, 2001, Cancer Res., 61, 8306

TUXHORN JA, 2002, Cancer Res., 62, 6021

10.1126/science.1090922

CHENG N, 2005, Oncogene, 24, 5053, 10.1038/sj.onc.1208685

SMITS A, 1992, Am. J. Pathol., 140, 639

COLTRERA MD, 1995, Cancer Res., 55, 2703

LINDMARK G, 1993, Lab. Invest., 69, 682

DE JONG JS, 1998, I: An inventory in search of autocrine and paracrine loops. J. Athol, 184, 44

DE JONG JS, 1998, II: Correlations with proliferation and angiogenesis. Pathol., 184, 53

10.1158/0008-5472.CAN-03-1489

ABRAMSSON A, 2003, J. Clin. Invest., 112, 1142, 10.1172/JCI200318549

SKOBE M, 1998, Proc. Natl. Acad. Sri. USA, 95, 1050, 10.1073/pnas.95.3.1050

10.1038/sj.onc.1203785

BASERGA R, 2003, Int J. Cancer, 107, 873, 10.1002/ijc.11487

SCHULER T, 2003, J. Exp. Med., 198, 1487, 10.1084/jem.20030849

ZOU W, 2005, Nat. Rev Cancer, 5, 263, 10.1038/nrc1586

LAZAR-MOLNAR E, 2000, Cytokthe, 12, 547

ORIMO A, 2001, Clin. Cancer Res., 7, 3097

ZHU X, 2000, Urology, 56, 1071, 10.1016/S0090-4295(00)00795-0

JOSEPH H, 1999, Mol Biol. Cell, 10, 1221, 10.1091/mbc.10.4.1221

OHIRA H, 1996, J. Hepatol., 25, 941, 10.1016/S0168-8278(96)80300-X

NAKAMURA T, 1997, Cancer Res., 57, 3305

GMYREK GA, 2001, Am. J. Pathol., 159, 579, 10.1016/S0002-9440(10)61729-4

BEVIGLIA L, 1997, Lit. J. Cancer, 74, 301

YAMASHITA J, 1994, Cancer Res., 54, 1630

TAKADA N, 1995, Cancer Lett., 97, 145, 10.1016/0304-3835(95)03967-2

MASUYA D, 2004, BE J. Cancer, 90, 1555, 10.1038/sj.bjc.6601718

10.1038/nrm1261

KUPERWASSER C, 2004, Proc. Nati Acad. Sri. USA, 101, 4966, 10.1073/pnas.0401064101

10.1023/A:1023768811842

10.1016/j.ccr.2004.05.032

LEBEDIS C, 2002, Int. J. Cancer, 100, 2, 10.1002/ijc.10481

GIRT D, 1999, Clin. Cancer Res., 5, 1063

10.1002/jcp.10142

NEWELL KJ, 1994, Mol Carcinog., 10, 199, 10.1002/mc.2940100404

HEPPNER KJ, 1996, Am. J. Patna, 149, 273

BISSON C, 2003, Int. J. Cancer, 105, 7, 10.1002/ijc.11012

STUELTEN CH, 2005, J. Cell &i., 118, 2143, 10.1242/jcs.02334

MASSON R, 1998, /. Cell Biol., 140, 1535, 10.1083/jcb.140.6.1535

ANDARAWEWA KL, 2003, Cancer Res., 63, 5844

NOEL A, 1998, Int. J. Cancer, 76, 267, 10.1002/(SICI)1097-0215(19980413)76:2<267::AID-IJC15>3.0.CO;2-9

ROSENTHAL EL, 2004, Arch. Otolaryngol. Head Neck Sorg., 130, 943, 10.1001/archotol.130.8.943

NIELSEN BS, 1996, Lab. Invest., 74, 168

TAN K, 1995, Int. J. Cancer, 60, 308, 10.1002/ijc.2910600305

ALMHOLT K, 2005, Int. J. Cancer, 113, 525, 10.1002/ijc.20631

BUGGE TH, 1998, Oncogene, 16, 3097, 10.1038/sj.onc.1201869

ALMHOLT K, 2003, Oncogene, 22, 4389, 10.1038/sj.onc.1206601

TURK V, 2004, Cancer Cell, 5, 409, 10.1016/S1535-6108(04)00117-5

JOYCE JA, 2004, Cancer Cell, 5, 443, 10.1016/S1535-6108(04)00111-4

TSE GM, 2004, Hum. Pathol, 35, 1053, 10.1016/j.humpath.2004.01.023

PILCH H, 2001, Int. J. Cynecol Cancer, 11, 137, 10.1046/j.1525-1438.2001.011002137.x

10.1016/S0092-8674(00)81731-6

10.1038/35000501

NUTT CL, 2003, Cancer Res., 63, 1602

GOLUB TR, 1999, Science, 286, 531, 10.1126/science.286.5439.531

XU XQ, 2005, J. Biol. Chem., 280, 23987, 10.1074/jbc.M503869200

MISCHEL PS, 2004, Nat Rev Neurosci., 5, 782, 10.1038/nrn1518

GREER BT, 2004, Ann. NY Acad. Sci., 1020, 49, 10.1196/annals.1310.007

STEARS RL, 2003, Nat. Med., 9, 140, 10.1038/nm0103-140

NAKAGAWA H, 2004, Oncogene, 23, 7366, 10.1038/sj.onc.1208013

WEAVER VM, 1995, Semi]. Cancer Biol., 6, 175, 10.1006/scbi.1995.0021

ALLINEN M, 2004, Cancer Cell, 6, 17, 10.1016/j.ccr.2004.06.010

PETERSEN OW, 2003, Am. J. Pathol, 162, 391, 10.1016/S0002-9440(10)63834-5

MICKE P, 2005, Methods Mol Biol., 293, 151

FUKUSHIMA N, 2004, Oncogene, 23, 9042, 10.1038/sj.onc.1208117

CHANG HY, 2002, Proc. Nati Acad. Sri. USA, 99, 12877, 10.1073/pnas.162488599

YINGLING JM, 2004, Nat. Rev Drug Discov., 3, 1011, 10.1038/nrd1580

10.1016/j.canlet.2004.09.044

BEHRENS P, 2003, InL J. Cancer, 107, 183, 10.1002/ijc.11336

MILLER KD, 2004, Clin. Cancer Res., 10, 1971, 10.1158/1078-0432.CCR-03-0968

SCOTT AM, 2003, Cita Cancer Res., 9, 1639

HOFHEINZ RD, 2003, Onkologie, 26, 44, 10.1159/000069863

DE WEVER O, 2003, Patna, 200, 429

JOYCE JA, 2005, Cancer Cell, 7, 513, 10.1016/j.ccr.2005.05.024